Risk of HBV Liver Disease in Isolated antiHbc Patients Receiving Immuno-Chemotherapy for Non Hodgkin Lymphoma

Haematologica - Italy
doi 10.3324/haematol.13750
Full Text
Abstract

Available in full text

Categories
Hematology
Date
Authors
Publisher

Ferrata Storti Foundation (Haematologica)

Related search

Longitudinal Risk of Herpes Zoster in Patients With Non-Hodgkin Lymphoma Receiving Chemotherapy: A Nationwide Population-Based Study

Scientific Reports
Multidisciplinary
2015English

Epidemiology of Chemotherapy-Induced Anemia in Patients With Non-Hodgkin Lymphoma

Permanente journal,The
Medicine
2019English

Occurrence of Sarcoidosis After Chemotherapy for Non-Hodgkin Lymphoma

Korean Journal of Internal Medicine
Internal Medicine
2016English

Non-Hodgkin Lymphoma Secondary to Cancer Chemotherapy

Cancer Epidemiology Biomarkers and Prevention
MedicineEpidemiologyOncology
2007English

Polymorphic MLH1 and Risk of Cancer After Methylating Chemotherapy for Hodgkin Lymphoma

Journal of Medical Genetics
Genetics
2007English

Occupation and the Risk of Non-Hodgkin Lymphoma

Cancer Epidemiology Biomarkers and Prevention
MedicineEpidemiologyOncology
2007English

Non-Hodgkin Lymphoma

2020English

The Prognostic Significance of Elevated Levels of Serum Ferritin Before Chemotherapy in Patients With Non-Hodgkin Lymphoma

Clinical Lymphoma, Myeloma and Leukemia
Cancer ResearchOncologyHematology
2014English

Polymorphisms in Complement System Genes and Risk of Non-Hodgkin Lymphoma

Environmental and Molecular Mutagenesis
MutagenesisToxicologyHealthGeneticsEpidemiology
2011English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy